150 related articles for article (PubMed ID: 2493376)
1. Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia.
Sumer T; Abumelha A; al-Mulhim I; al-Fadil M
Eur J Pediatr; 1989 Feb; 148(5):401-2. PubMed ID: 2493376
[TBL] [Abstract][Full Text] [Related]
2. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
Martino P; Venditti M; Petti MC; Mandelli F; Serra P
Infection; 1985; 13(3):125-9. PubMed ID: 3928495
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
7. Fever and neutropenia during intensive chemotherapy.
Klastersky J
Ann Oncol; 1993 Aug; 4(7):603-6. PubMed ID: 8363991
[No Abstract] [Full Text] [Related]
8. Comparison of two versus three daily infusions of cefotaxime plus amikacin in granulocytopenic children.
Vannier JP; Gardembas-Pain M; Blaysat G; Lemeland JF; Tron P
Drugs; 1988; 35 Suppl 2():231. PubMed ID: 3396486
[No Abstract] [Full Text] [Related]
9. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Yataganas X; Rombos Y; Vayopoulos G; Meletis J; Avlami A
Chemotherapy; 1991; 37(5):376-81. PubMed ID: 1804599
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of empirical antibiotic therapy in the control of infections in patients with acute leukemia during severe neutropenia].
Hansz J; Woźny T; Bajko G; Drozdowska D
Pol Arch Med Wewn; 1992 Jun; 87(6):379-85. PubMed ID: 1408996
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia.
Schmid L; Jeschko M; Wilder-Smith C; Schafroth U; Thürlimann B; Pedrazzini A; Senn H
Chemotherapy; 1991; 37(5):346-52. PubMed ID: 1804595
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of the effects on the oral mucosa of treatment for acute childhood leukaemia.
Williams MC; Martin MV
Int J Paediatr Dent; 1992 Aug; 2(2):73-9. PubMed ID: 1420098
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
[TBL] [Abstract][Full Text] [Related]
15. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients.
Borbolla JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba E; Alvarado ML; Jiménez RM
Chemotherapy; 2001; 47(5):381-4. PubMed ID: 11561142
[TBL] [Abstract][Full Text] [Related]
18. The cause of fever following resolution of neutropenia in patients with acute leukemia.
Barton TD; Schuster MG
Clin Infect Dis; 1996 Jun; 22(6):1064-8. PubMed ID: 8783711
[TBL] [Abstract][Full Text] [Related]
19. Isolation frequency and antimicrobial susceptibility of Pseudomonas aeruginosa bloodstream infections in neutropenic patients with acute leukemia.
Fanci R; Paci C; Pecile P
J Chemother; 2001 Apr; 13(2):213-5. PubMed ID: 11330372
[No Abstract] [Full Text] [Related]
20. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
